ES2186792T3 - Metodos de fabricar liposomas que contienen fotosensibilizantes hidro-monobenzoporfirinicos. - Google Patents

Metodos de fabricar liposomas que contienen fotosensibilizantes hidro-monobenzoporfirinicos.

Info

Publication number
ES2186792T3
ES2186792T3 ES96925614T ES96925614T ES2186792T3 ES 2186792 T3 ES2186792 T3 ES 2186792T3 ES 96925614 T ES96925614 T ES 96925614T ES 96925614 T ES96925614 T ES 96925614T ES 2186792 T3 ES2186792 T3 ES 2186792T3
Authority
ES
Spain
Prior art keywords
photosensitizers
monobenzoporphyrinic
methods
liposomes containing
manufacturing liposomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96925614T
Other languages
English (en)
Inventor
Liu Ron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novelion Therapeutics Inc
Original Assignee
QLT Inc
Quadra Logic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QLT Inc, Quadra Logic Technologies Inc filed Critical QLT Inc
Application granted granted Critical
Publication of ES2186792T3 publication Critical patent/ES2186792T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

METODOS PARA HACER UNA COMPOSICION FARMACEUTICA QUE CONTIENE LIPOSOMAS, CUYOS LIPOSOMAS COMPRENDEN UNA CANTIDAD TERAPEUTICAMENTE ACEPTABLE DE UNA HIDROMONOBENZOPORFIRINA FOTOSENSIBILIZADORA Y UNA MEZCLA DE FOSFOLIPIDOS QUE COMPRENDEN FOSFATIDIL GLICEROL DE HUEVO ( EPG ) Y DIMIRISTOIL FOSFATIDIL COLINA ("DMPC ). EL METODO COMPRENDE LOS SIGUIENTES PASOS: A) COMBINACION DEL FOTOSENSIBILIZADOR Y DE LOS FOSFOLIPIDOS EN UNA RELACION MOLAR DE ALREDEDOR DE 1:7,0 O MAS FOSFOLIPIDOS EN PRESENCIA DE UN DISOLVENTE ORGANICO; B) ELIMINACION DEL DISOLVENTE ORGANICO PARA FORMAR UNA PELICULA LIPIDICA; C) HIDRATACION DE LA PELICULA LIPIDICA CON UNA SOLUCION ACUOSA A UNA TEMPERATURA POR DEBAJO DE UNOS 300 (GRADOS) C, PARA FORMAR LIPOSOMAS GROSEROS QUE CONTIENEN UN COMPLEJO FOTOSENSIBILIZADORFOSFOLIPIDO; Y D) HOMOGENEIZACION O REDUCCION DE LA DIMENSION DE LAS PARTICULAS DE LOS LIPOSOMAS GROSEROS HASTA UN RANGO DE TAMAÑO DE PARTICULA DE ALREDEDOR DE 150 A 300 NM A UNA TEMPERATURA POR DEBAJO DE UNOS 300 (GRADOS)C. LA INVENCION TAMBIEN CONTEMPLA LAS COMPOSICIONES FARMACEUTICAS LIPOSOMICAS EN SI MISMAS.
ES96925614T 1995-08-02 1996-07-29 Metodos de fabricar liposomas que contienen fotosensibilizantes hidro-monobenzoporfirinicos. Expired - Lifetime ES2186792T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/510,573 US5707608A (en) 1995-08-02 1995-08-02 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer

Publications (1)

Publication Number Publication Date
ES2186792T3 true ES2186792T3 (es) 2003-05-16

Family

ID=24031289

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96925614T Expired - Lifetime ES2186792T3 (es) 1995-08-02 1996-07-29 Metodos de fabricar liposomas que contienen fotosensibilizantes hidro-monobenzoporfirinicos.

Country Status (12)

Country Link
US (1) US5707608A (es)
EP (1) EP0843547B1 (es)
JP (1) JP3782112B2 (es)
AT (1) ATE226430T1 (es)
AU (1) AU717181B2 (es)
CA (1) CA2227761C (es)
DE (1) DE69624485T2 (es)
DK (1) DK0843547T3 (es)
ES (1) ES2186792T3 (es)
PT (1) PT843547E (es)
TW (1) TW585785B (es)
WO (1) WO1997004746A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69215722T3 (de) * 1991-03-22 2001-03-08 Katsuro Tachibana Verstärker zur Ultraschalltherapie von Erkrankungen sowie diesen enthaltende flüssige Arzneimittelzusammensetzungen
US6890555B1 (en) * 1992-02-05 2005-05-10 Qlt, Inc. Liposome compositions of porphyrin photosensitizers
US6176842B1 (en) 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US6210356B1 (en) * 1998-08-05 2001-04-03 Ekos Corporation Ultrasound assembly for use with a catheter
US6143287A (en) * 1996-02-27 2000-11-07 New York Blood Center, Inc. Method and composition for hair removal
CA2202103C (en) 1996-04-11 2007-01-09 Toshiaki Tagawa Method for preparing closed vesicles
JP2001511128A (ja) * 1997-01-28 2001-08-07 ファルマシア・アンド・アップジョン・カンパニー 水不溶性ポルフィリンの脂質錯体の凍結乾燥物
US6582392B1 (en) * 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
WO1999013916A2 (en) * 1997-09-18 1999-03-25 Nycomed Imaging As Methods and compositions for medical imaging
US6183727B1 (en) 1998-05-19 2001-02-06 Arizona Board Of Regents Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis
US6608050B2 (en) * 1999-07-20 2003-08-19 Pharmacia & Upjohn Company Lyophilizate of lipid complex of water insoluble porphyrins
US6351663B1 (en) 1999-09-10 2002-02-26 Akorn, Inc. Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
US6944493B2 (en) * 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
US6443976B1 (en) 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
AU2001234979B2 (en) 2000-02-10 2006-07-27 Massachusetts Eye And Ear Infirmary Methods and compositions for treating conditions of the eye
IL151833A0 (en) * 2000-03-24 2003-04-10 Novartis Ag Improved treatment of neovascularization
WO2002064163A2 (en) 2001-02-15 2002-08-22 Qlt Inc. Reduction or prevention of pdt related inflammation
AU2007202603B2 (en) * 2001-04-11 2010-06-10 Valeant Pharmaceuticals International, Inc. Drug delivery system for hydrophobic drugs
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
WO2003037295A2 (en) * 2001-11-02 2003-05-08 The Governors Of The University Of Alberta Micelle compositions containing pegylated phospholipids and a photosensitizer
ATE520362T1 (de) 2001-12-03 2011-09-15 Ekos Corp Katheter mit mehreren ultraschall-abstrahlenden teilen
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
US7455858B2 (en) * 2002-05-16 2008-11-25 Qlt Inc. Compositions and methods for delivery of photosensitive drugs
US6921371B2 (en) * 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
US20040220167A1 (en) * 2003-05-02 2004-11-04 Nasrollah Samiy Methods of treating neuralgic pain
JP4741205B2 (ja) * 2003-07-07 2011-08-03 真 湯浅 金属ポルフィリン錯体包埋リポソーム、その製造方法およびこれを利用する医薬
US7682603B2 (en) * 2003-07-25 2010-03-23 The Trustees Of The University Of Pennsylvania Polymersomes incorporating highly emissive probes
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
US7341569B2 (en) 2004-01-30 2008-03-11 Ekos Corporation Treatment of vascular occlusions using ultrasonic energy and microbubbles
US7419666B1 (en) 2004-02-23 2008-09-02 Massachusetts Eye And Ear Infirmary Treatment of ocular disorders
EP1874197A4 (en) * 2005-04-12 2010-02-10 Ekos Corp ULTRASONIC SURFACE CATHETER PROMOTING CAVITATION
EP2015846A2 (en) 2006-04-24 2009-01-21 Ekos Corporation Ultrasound therapy system
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
WO2008088037A1 (ja) * 2007-01-18 2008-07-24 National University Corporation Chiba University 微粒子製剤
EP2494932B1 (en) 2007-06-22 2020-05-20 Ekos Corporation Apparatus for treatment of intracranial hemorrhages
EP2231024A4 (en) * 2007-12-14 2015-03-18 Ekos Corp ULTRASOUND PULSE SHAPING
US9211214B2 (en) 2012-03-21 2015-12-15 Valeant Pharmaceuticals International, Inc Photodynamic therapy laser
US10918599B2 (en) * 2015-04-02 2021-02-16 The Research Foundation For The State University Of New York Serum-stable compositions and methods for light-triggered release of materials
EP3307388B1 (en) 2015-06-10 2022-06-22 Ekos Corporation Ultrasound catheter
JP7079937B2 (ja) 2016-05-26 2022-06-03 ユニバーシティ オブ ピッツバーグ －オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 肺血管疾患を治療するための組成物および方法
KR102035384B1 (ko) * 2017-06-26 2019-10-22 서강대학교산학협력단 광감작제를 포함한 마이크로버블-나노입자 복합체 및 이를 포함하는 항암 치료제

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500507A (en) * 1981-10-30 1985-02-19 Wong Dennis W Diagnostic composition for radiologic imaging of neoplasms in the body and method of preparation
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4577636A (en) * 1982-11-23 1986-03-25 The Beth Israel Hospital Association Method for diagnosis of atherosclerosis
US4517762A (en) * 1983-07-08 1985-05-21 Venetz Louis M Animal trap holder
US4485806A (en) * 1983-10-24 1984-12-04 Calspan Corporation Method and apparatus for evacuating contaminated casualties
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
US4776991A (en) * 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
US4933121A (en) * 1986-12-10 1990-06-12 Ciba Corning Diagnostics Corp. Process for forming liposomes
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
US5214036A (en) * 1990-03-08 1993-05-25 University Of British Columbia Benzoporphyrin derivatives for photodynamic therapy
US5053423A (en) * 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5238940A (en) * 1990-03-22 1993-08-24 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5270053A (en) * 1990-04-03 1993-12-14 Ciba-Geigy Corp. Parenterally administerable liposome formulation comprising synthetic lipid
CA2047969A1 (en) * 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
US5422362A (en) * 1993-07-29 1995-06-06 Quadra Logic Technologies, Inc. Method to inhibit restenosis

Also Published As

Publication number Publication date
EP0843547B1 (en) 2002-10-23
AU717181B2 (en) 2000-03-16
CA2227761A1 (en) 1997-02-13
DE69624485T2 (de) 2003-06-26
DE69624485D1 (de) 2002-11-28
PT843547E (pt) 2003-03-31
EP0843547A1 (en) 1998-05-27
ATE226430T1 (de) 2002-11-15
TW585785B (en) 2004-05-01
WO1997004746A1 (en) 1997-02-13
JP3782112B2 (ja) 2006-06-07
AU6608396A (en) 1997-02-26
DK0843547T3 (da) 2003-02-24
US5707608A (en) 1998-01-13
CA2227761C (en) 2004-01-06

Similar Documents

Publication Publication Date Title
ES2186792T3 (es) Metodos de fabricar liposomas que contienen fotosensibilizantes hidro-monobenzoporfirinicos.
ES2153053T3 (es) Liposomas de eter-lipido y su uso terapeutico.
PA8481501A1 (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
ATE192924T1 (de) Liposomal verkapseltes taxol, seine herstellung und seine verwendung
ES2036593T3 (es) Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
FI965144A0 (fi) Sterolijohdannaiset käytettäviksi meioosin säätelyyn
TR199800415T1 (en) Farmas�tik form�lasyon.
ES2182869T3 (es) Sacarido no reductor y su uso.
HN2002000327A (es) DERIVADOS DE TRIAZOLO [4, 3-a] PIRIDO [2, 3-d] PIRIMIDIN-5-ONA, COMPOSICIONES QUE LOS CONTIENEN, METODO DE PREPARACION Y USO
GR3018810T3 (en) 5,6-dihydroxyindoline as additives for hair-dyeing preparations.
ATE159250T1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
ATE233484T1 (de) Desinfizierende zusammensetzung
DE59912159D1 (de) Phospholipide mit ungesattigten alkyl- und acylketten
ES2041617T1 (es) Intermediarios para agentes quelatinosos con simetria prefijada y proceso para su preparacion.
TR200401051T4 (tr) 3-amino-2-kloro-4-etilpiridin yapım işlemi
JPS55160712A (en) Emulsified cosmetic composition
ID27440A (id) Proses untuk menyiapkan penengah-penengah
DE3851842D1 (de) Wässrige bereitung von liposomenzusammensetzungen.
TR199900748A2 (xx) Osteinduktif protein ve dorsalize faktörünün kombinasyonunun kullanılması.
SE8400118L (sv) Substituerade karboxi-tiazolo/3,2-a/pyrimidinderivat och forfarande for deras framstellning
RU94027343A (ru) Липосомальная везикула с цитохромом с
ES8206507A1 (es) Procedimiento para la obtencion de las sustancias odoriferas metil-4-oxatricilo 5,2,1,0,6-dec-8-en-3-ona y decan-3-ona.
Chiesi Characteristics of cardiac sarcoplasmic reticulum and of its Ca-(2+)-pumping enzyme: a comparative study with fast skeletal muscle
ES2106858T3 (es) Nuevos derivados de la citarabina, su procedimiento de preparacion y su uso contra enfermedades cancerosas.
ECSP003415A (es) Derivados de 3-amino,3-arilpropan- 1 - ol, su preparacion y su uso